Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center.
Identifieur interne : 000036 ( Main/Corpus ); précédent : 000035; suivant : 000037Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center.
Auteurs : Michelle Lubetzky ; Meredith J. Aull ; Rebecca Craig-Schapiro ; John R. Lee ; Jehona Marku-Podvorica ; Thalia Salinas ; Laura Gingras ; Jun B. Lee ; Samuel Sultan ; Rosy Priya Kodiyanplakkal ; Choli Hartono ; Stuart Saal ; Thangamani Muthukumar ; Sandip Kapur ; Manikkam Suthanthiran ; Darshana M. DadhaniaSource :
- Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [ 1460-2385 ] ; 2020.
Abstract
BACKGROUND
Kidney graft recipients receiving immunosuppressive therapy may be at heightened risk for coronavirus disease 2019 (Covid-19) and adverse outcomes. It is therefore important to characterize the clinical course and outcome of Covid-19 in this population and identify safe therapeutic strategies.
METHODS
We performed a retrospective chart review of 73 adult kidney graft recipients evaluated for Covid-19 from 13 March to 20 April 2020. Primary outcomes included recovery from symptoms, acute kidney injury, graft failure and case fatality rate.
RESULTS
Of the 73 patients screened, 54 tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-39 with moderate to severe symptoms requiring hospital admission and 15 with mild symptoms managed in the ambulatory setting. Hospitalized patients were more likely to be male, of Hispanic ethnicity and to have cardiovascular disease. In the hospitalized group, tacrolimus dosage was reduced in 46% of patients and mycophenolate mofetil (MMF) therapy was stopped in 61% of patients. None of the ambulatory patients had tacrolimus reduction or discontinuation of MMF. Azithromycin or doxycycline was prescribed at a similar rate among hospitalized and ambulatory patients (38% versus 40%). Hydroxychloroquine was prescribed in 79% of hospitalized patients. Graft failure requiring hemodialysis occurred in 3 of 39 hospitalized patients (8%) and 7 patients died, resulting in a case fatality rate of 13% among Covid-19-positive patients and 18% among hospitalized Covid-19-positive patients.
CONCLUSIONS
Data from our study suggest that a strategy of systematic triage to outpatient or inpatient care, early management of concurrent bacterial infections and judicious adjustment of immunosuppressive drugs rather than cessation is feasible in kidney transplant recipients with Covid-19.
DOI: 10.1093/ndt/gfaa154
PubMed: 32678882
Links to Exploration step
pubmed:32678882Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center.</title><author><name sortKey="Lubetzky, Michelle" sort="Lubetzky, Michelle" uniqKey="Lubetzky M" first="Michelle" last="Lubetzky">Michelle Lubetzky</name><affiliation><nlm:affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Aull, Meredith J" sort="Aull, Meredith J" uniqKey="Aull M" first="Meredith J" last="Aull">Meredith J. Aull</name><affiliation><nlm:affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Division of Transplant Surgery, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Craig Schapiro, Rebecca" sort="Craig Schapiro, Rebecca" uniqKey="Craig Schapiro R" first="Rebecca" last="Craig-Schapiro">Rebecca Craig-Schapiro</name><affiliation><nlm:affiliation>Division of Transplant Surgery, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Lee, John R" sort="Lee, John R" uniqKey="Lee J" first="John R" last="Lee">John R. Lee</name><affiliation><nlm:affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Marku Podvorica, Jehona" sort="Marku Podvorica, Jehona" uniqKey="Marku Podvorica J" first="Jehona" last="Marku-Podvorica">Jehona Marku-Podvorica</name><affiliation><nlm:affiliation>Division of Transplant Surgery, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Salinas, Thalia" sort="Salinas, Thalia" uniqKey="Salinas T" first="Thalia" last="Salinas">Thalia Salinas</name><affiliation><nlm:affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Gingras, Laura" sort="Gingras, Laura" uniqKey="Gingras L" first="Laura" last="Gingras">Laura Gingras</name><affiliation><nlm:affiliation>Department of Internal Medicine, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Lee, Jun B" sort="Lee, Jun B" uniqKey="Lee J" first="Jun B" last="Lee">Jun B. Lee</name><affiliation><nlm:affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Sultan, Samuel" sort="Sultan, Samuel" uniqKey="Sultan S" first="Samuel" last="Sultan">Samuel Sultan</name><affiliation><nlm:affiliation>Division of Transplant Surgery, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Kodiyanplakkal, Rosy Priya" sort="Kodiyanplakkal, Rosy Priya" uniqKey="Kodiyanplakkal R" first="Rosy Priya" last="Kodiyanplakkal">Rosy Priya Kodiyanplakkal</name><affiliation><nlm:affiliation>Division of Infectious Disease, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Hartono, Choli" sort="Hartono, Choli" uniqKey="Hartono C" first="Choli" last="Hartono">Choli Hartono</name><affiliation><nlm:affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Saal, Stuart" sort="Saal, Stuart" uniqKey="Saal S" first="Stuart" last="Saal">Stuart Saal</name><affiliation><nlm:affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Muthukumar, Thangamani" sort="Muthukumar, Thangamani" uniqKey="Muthukumar T" first="Thangamani" last="Muthukumar">Thangamani Muthukumar</name><affiliation><nlm:affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Kapur, Sandip" sort="Kapur, Sandip" uniqKey="Kapur S" first="Sandip" last="Kapur">Sandip Kapur</name><affiliation><nlm:affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Division of Transplant Surgery, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Suthanthiran, Manikkam" sort="Suthanthiran, Manikkam" uniqKey="Suthanthiran M" first="Manikkam" last="Suthanthiran">Manikkam Suthanthiran</name><affiliation><nlm:affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Dadhania, Darshana M" sort="Dadhania, Darshana M" uniqKey="Dadhania D" first="Darshana M" last="Dadhania">Darshana M. Dadhania</name><affiliation><nlm:affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32678882</idno><idno type="pmid">32678882</idno><idno type="doi">10.1093/ndt/gfaa154</idno><idno type="wicri:Area/Main/Corpus">000036</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000036</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center.</title><author><name sortKey="Lubetzky, Michelle" sort="Lubetzky, Michelle" uniqKey="Lubetzky M" first="Michelle" last="Lubetzky">Michelle Lubetzky</name><affiliation><nlm:affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Aull, Meredith J" sort="Aull, Meredith J" uniqKey="Aull M" first="Meredith J" last="Aull">Meredith J. Aull</name><affiliation><nlm:affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Division of Transplant Surgery, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Craig Schapiro, Rebecca" sort="Craig Schapiro, Rebecca" uniqKey="Craig Schapiro R" first="Rebecca" last="Craig-Schapiro">Rebecca Craig-Schapiro</name><affiliation><nlm:affiliation>Division of Transplant Surgery, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Lee, John R" sort="Lee, John R" uniqKey="Lee J" first="John R" last="Lee">John R. Lee</name><affiliation><nlm:affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Marku Podvorica, Jehona" sort="Marku Podvorica, Jehona" uniqKey="Marku Podvorica J" first="Jehona" last="Marku-Podvorica">Jehona Marku-Podvorica</name><affiliation><nlm:affiliation>Division of Transplant Surgery, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Salinas, Thalia" sort="Salinas, Thalia" uniqKey="Salinas T" first="Thalia" last="Salinas">Thalia Salinas</name><affiliation><nlm:affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Gingras, Laura" sort="Gingras, Laura" uniqKey="Gingras L" first="Laura" last="Gingras">Laura Gingras</name><affiliation><nlm:affiliation>Department of Internal Medicine, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Lee, Jun B" sort="Lee, Jun B" uniqKey="Lee J" first="Jun B" last="Lee">Jun B. Lee</name><affiliation><nlm:affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Sultan, Samuel" sort="Sultan, Samuel" uniqKey="Sultan S" first="Samuel" last="Sultan">Samuel Sultan</name><affiliation><nlm:affiliation>Division of Transplant Surgery, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Kodiyanplakkal, Rosy Priya" sort="Kodiyanplakkal, Rosy Priya" uniqKey="Kodiyanplakkal R" first="Rosy Priya" last="Kodiyanplakkal">Rosy Priya Kodiyanplakkal</name><affiliation><nlm:affiliation>Division of Infectious Disease, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Hartono, Choli" sort="Hartono, Choli" uniqKey="Hartono C" first="Choli" last="Hartono">Choli Hartono</name><affiliation><nlm:affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Saal, Stuart" sort="Saal, Stuart" uniqKey="Saal S" first="Stuart" last="Saal">Stuart Saal</name><affiliation><nlm:affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Muthukumar, Thangamani" sort="Muthukumar, Thangamani" uniqKey="Muthukumar T" first="Thangamani" last="Muthukumar">Thangamani Muthukumar</name><affiliation><nlm:affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Kapur, Sandip" sort="Kapur, Sandip" uniqKey="Kapur S" first="Sandip" last="Kapur">Sandip Kapur</name><affiliation><nlm:affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Division of Transplant Surgery, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Suthanthiran, Manikkam" sort="Suthanthiran, Manikkam" uniqKey="Suthanthiran M" first="Manikkam" last="Suthanthiran">Manikkam Suthanthiran</name><affiliation><nlm:affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Dadhania, Darshana M" sort="Dadhania, Darshana M" uniqKey="Dadhania D" first="Darshana M" last="Dadhania">Darshana M. Dadhania</name><affiliation><nlm:affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</title><idno type="eISSN">1460-2385</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Kidney graft recipients receiving immunosuppressive therapy may be at heightened risk for coronavirus disease 2019 (Covid-19) and adverse outcomes. It is therefore important to characterize the clinical course and outcome of Covid-19 in this population and identify safe therapeutic strategies.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>We performed a retrospective chart review of 73 adult kidney graft recipients evaluated for Covid-19 from 13 March to 20 April 2020. Primary outcomes included recovery from symptoms, acute kidney injury, graft failure and case fatality rate.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Of the 73 patients screened, 54 tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-39 with moderate to severe symptoms requiring hospital admission and 15 with mild symptoms managed in the ambulatory setting. Hospitalized patients were more likely to be male, of Hispanic ethnicity and to have cardiovascular disease. In the hospitalized group, tacrolimus dosage was reduced in 46% of patients and mycophenolate mofetil (MMF) therapy was stopped in 61% of patients. None of the ambulatory patients had tacrolimus reduction or discontinuation of MMF. Azithromycin or doxycycline was prescribed at a similar rate among hospitalized and ambulatory patients (38% versus 40%). Hydroxychloroquine was prescribed in 79% of hospitalized patients. Graft failure requiring hemodialysis occurred in 3 of 39 hospitalized patients (8%) and 7 patients died, resulting in a case fatality rate of 13% among Covid-19-positive patients and 18% among hospitalized Covid-19-positive patients.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Data from our study suggest that a strategy of systematic triage to outpatient or inpatient care, early management of concurrent bacterial infections and judicious adjustment of immunosuppressive drugs rather than cessation is feasible in kidney transplant recipients with Covid-19.</p></div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32678882</PMID><DateRevised><Year>2020</Year><Month>07</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2385</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Jul</Month><Day>17</Day></PubDate></JournalIssue><Title>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</Title><ISOAbbreviation>Nephrol. Dial. Transplant.</ISOAbbreviation></Journal><ArticleTitle>Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">gfaa154</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ndt/gfaa154</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Kidney graft recipients receiving immunosuppressive therapy may be at heightened risk for coronavirus disease 2019 (Covid-19) and adverse outcomes. It is therefore important to characterize the clinical course and outcome of Covid-19 in this population and identify safe therapeutic strategies.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a retrospective chart review of 73 adult kidney graft recipients evaluated for Covid-19 from 13 March to 20 April 2020. Primary outcomes included recovery from symptoms, acute kidney injury, graft failure and case fatality rate.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 73 patients screened, 54 tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-39 with moderate to severe symptoms requiring hospital admission and 15 with mild symptoms managed in the ambulatory setting. Hospitalized patients were more likely to be male, of Hispanic ethnicity and to have cardiovascular disease. In the hospitalized group, tacrolimus dosage was reduced in 46% of patients and mycophenolate mofetil (MMF) therapy was stopped in 61% of patients. None of the ambulatory patients had tacrolimus reduction or discontinuation of MMF. Azithromycin or doxycycline was prescribed at a similar rate among hospitalized and ambulatory patients (38% versus 40%). Hydroxychloroquine was prescribed in 79% of hospitalized patients. Graft failure requiring hemodialysis occurred in 3 of 39 hospitalized patients (8%) and 7 patients died, resulting in a case fatality rate of 13% among Covid-19-positive patients and 18% among hospitalized Covid-19-positive patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Data from our study suggest that a strategy of systematic triage to outpatient or inpatient care, early management of concurrent bacterial infections and judicious adjustment of immunosuppressive drugs rather than cessation is feasible in kidney transplant recipients with Covid-19.</AbstractText><CopyrightInformation>© The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lubetzky</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aull</LastName><ForeName>Meredith J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Transplant Surgery, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Craig-Schapiro</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Transplant Surgery, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marku-Podvorica</LastName><ForeName>Jehona</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Transplant Surgery, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salinas</LastName><ForeName>Thalia</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gingras</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jun B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sultan</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Transplant Surgery, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kodiyanplakkal</LastName><ForeName>Rosy Priya</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartono</LastName><ForeName>Choli</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saal</LastName><ForeName>Stuart</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muthukumar</LastName><ForeName>Thangamani</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapur</LastName><ForeName>Sandip</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Transplant Surgery, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suthanthiran</LastName><ForeName>Manikkam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dadhania</LastName><ForeName>Darshana M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nephrol Dial Transplant</MedlineTA><NlmUniqueID>8706402</NlmUniqueID><ISSNLinking>0931-0509</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">immunosuppression</Keyword><Keyword MajorTopicYN="N">kidney transplantation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>05</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32678882</ArticleId><ArticleId IdType="pii">5873247</ArticleId><ArticleId IdType="doi">10.1093/ndt/gfaa154</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CardioCovidV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000036 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000036 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CardioCovidV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32678882
|texte= Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32678882" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CardioCovidV1
| This area was generated with Dilib version V0.6.35. |  |